• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples

tetano

Editor, Senior Moderator
J Clin Virol. 2020 Apr 22;127:104381. doi: 10.1016/j.jcv.2020.104381. [Epub ahead of print]
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.


Eis-H?binger AM[SUP]1[/SUP], H?nemann M[SUP]2[/SUP], Wenzel JJ[SUP]3[/SUP], Berger A[SUP]4[/SUP], Widera M[SUP]4[/SUP], Schmidt B[SUP]3[/SUP], Aldabbagh S[SUP]1[/SUP], Marx B[SUP]1[/SUP], Streeck H[SUP]1[/SUP], Ciesek S[SUP]4[/SUP], Liebert UG[SUP]2[/SUP], Huzly D[SUP]5[/SUP], Hengel H[SUP]5[/SUP], Panning M[SUP]6[/SUP].

Author information




Abstract

BACKGROUND:

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in late 2019 and subsequently caused a pandemic. Surveillance is important to better appreciate this evolving pandemic and to longitudinally monitor the effectiveness of public health measures.
OBJECTIVES:

We aimed to provide a rapid, easy to establish and costeffective laboratory-based surveillance tool for SARS-CoV-2.
STUDY DESIGN:

We used minipools of RNA prepared from nucleic acid extractions of routine respiratory samples. We technically validated the assay and distributed the protocol within an informal network of five German university laboratories.
RESULTS:

We tested a total of 70 minipools resembling 700 samples shortly before the upsurge of cases in Germany from 17.02.2020 to 10.03.2020. One minipool reacted positive and after resolution one individual sample tested SARS-CoV-2 positive. This sample was from a hospitalized patient not suspected of having contracted SARS-CoV-2.
CONCLUSIONS:

Our approach of a laboratory-based surveillance for SARSCoV-2 using minipools proved its concept is easily adaptable and resource-saving. It might assist not only public health laboratories in SARS-CoV-2 surveillance.
Copyright ? 2020 Elsevier B.V. All rights reserved.



KEYWORDS:

Laboratory; Minipools; RT-PCR; SARS-CoV-2; Surveillance


PMID:32344319PMCID:PMC7175872DOI:10.1016/j.jcv.2020.104381
Free PMC Article
 
Back
Top